Synlogic, Inc. (SYBX) stock
SYBXOTCPharmaceutical PreparationsFiscal year ends December 31
$1.07+0.07 (+7.00%)
Close on Oct 19, 2026Market cap $13.29MP/E –Yield –
Synlogic net income
Net income is the profit left for shareholders after every expense, interest and tax.
Synlogic's net income for the twelve months ending Sep 30, 2026 was -$2.23M. For fiscal 2025 it was -$1.01M. The highest annual figure on record is -$1.01M in fiscal 2025.
Annual net income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$1.01M | – |
| FY2024 | Dec 31, 2024 | -$23.36M | – |
| FY2023 | Dec 31, 2023 | -$61.27M | – |
| FY2022 | Dec 31, 2022 | -$66.15M | – |
| FY2021 | Dec 31, 2021 | -$60.56M | – |
| FY2020 | Dec 31, 2020 | -$59.17M | – |
| FY2019 | Dec 31, 2019 | -$51.37M | – |
| FY2018 | Dec 31, 2018 | -$48.44M | – |
| FY2017 | Dec 31, 2017 | -$40.38M | – |
| FY2016 | Dec 31, 2016 | -$20.95M | – |
| FY2015 | Dec 31, 2015 | -$24.98M | – |
| FY2014 | Dec 31, 2014 | -$15.83M | – |
| FY2013 | Dec 31, 2013 | -$6.44M | – |
Quarterly net income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026 | Sep 30, 2026 | -$3.87M | – |
| Q2 FY2026 | Jun 30, 2026 | -$543.00K | – |
| Q1 FY2026 | Mar 31, 2026 | $681.00K | +114.8% |
| Q4 FY2025 | Dec 31, 2025 | $1.51M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.30M | – |
| Q2 FY2025 | Jun 30, 2025 | -$529.00K | -117.2% |
| Q1 FY2025 | Mar 31, 2025 | $317.00K | – |
| Q4 FY2024 | Dec 31, 2024 | -$714.00K | – |
| Q3 FY2024 | Sep 30, 2024 | -$117.00K | – |
| Q2 FY2024 | Jun 30, 2024 | $3.08M | – |
| Q1 FY2024 | Mar 31, 2024 | -$25.61M | – |
| Q4 FY2023 | Dec 31, 2023 | -$18.53M | – |
| Q3 FY2023 | Sep 30, 2023 | -$12.08M | – |
| Q2 FY2023 | Jun 30, 2023 | -$15.05M | – |
| Q1 FY2023 | Mar 31, 2023 | -$15.62M | – |
| Q4 FY2022 | Dec 31, 2022 | -$16.70M | – |
| Q3 FY2022 | Sep 30, 2022 | -$17.91M | – |
| Q2 FY2022 | Jun 30, 2022 | -$15.84M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.70M | – |
| Q4 FY2021 | Dec 31, 2021 | -$15.09M | – |
| Q3 FY2021 | Sep 30, 2021 | -$16.02M | – |
| Q2 FY2021 | Jun 30, 2021 | -$14.49M | – |
| Q1 FY2021 | Mar 31, 2021 | -$14.97M | – |
| Q4 FY2020 | Dec 31, 2020 | -$14.59M | – |
| Q3 FY2020 | Sep 30, 2020 | -$13.22M | – |
| Q2 FY2020 | Jun 30, 2020 | -$15.54M | – |
| Q1 FY2020 | Mar 31, 2020 | -$15.83M | – |
| Q4 FY2019 | Dec 31, 2019 | -$12.80M | – |
| Q3 FY2019 | Sep 30, 2019 | -$13.29M | – |
| Q2 FY2019 | Jun 30, 2019 | -$12.34M | – |
| Q1 FY2019 | Mar 31, 2019 | -$12.95M | – |
| Q4 FY2018 | Dec 31, 2018 | -$11.93M | – |
| Q3 FY2018 | Sep 30, 2018 | -$10.75M | – |
| Q2 FY2018 | Jun 30, 2018 | -$14.59M | – |
| Q1 FY2018 | Mar 31, 2018 | -$11.17M | – |
| Q4 FY2017 | Dec 31, 2017 | -$11.70M | – |
| Q3 FY2017 | Sep 30, 2017 | -$11.92M | – |
| Q2 FY2017 | Jun 30, 2017 | -$9.39M | – |
| Q1 FY2017 | Mar 31, 2017 | -$7.37M | – |
| Q4 FY2016 | Dec 31, 2016 | -$6.85M | – |
See a number that looks wrong?